A review of selected chemical additives in cosmetic products

Dermatologic Therapy

Volumn 27, Issue 6, 2014, Pages 317-322

  Juhász, Margit Lai Wun ^a   Marmur, Ellen S ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Marmur Medical New York   (United States)

Author keywords

skin barrier; therapy topical

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; ANTIPERSPIRANT AGENT; BUTYL PARABEN; COSMETIC; DEODORANT AGENT; DIOXANE; FORMALDEHYDE; HAIR DYE; LEAD; LEAD ACETATE; METHYL PARABEN; PHTHALIC ACID; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID ESTER; 1,4-DIOXANE; DIOXANE DERIVATIVE; EMULSIFYING AGENT; ORGANOMETALLIC COMPOUND; PHTHALIC ACID DERIVATIVE; PRESERVATIVE;

BREAST CANCER; CANCER RISK; CHEMICAL CARCINOGENESIS; CHEMICAL SAFETY; CONTACT DERMATITIS; FOOD AND DRUG ADMINISTRATION; HEALTH HAZARD; HUMAN; KERATINOCYTE; MYELOID LEUKEMIA; NASOPHARYNX CANCER; NONHUMAN; PACKAGING; PRODUCT SAFETY; REVIEW; SKIN ABSORPTION; SKIN TOXICITY; ULTRAVIOLET B RADIATION; ANIMAL; CHEMISTRY; RISK ASSESSMENT; RISK FACTOR; STANDARDS;

ANIMALS; CONSUMER PRODUCT SAFETY; COSMETICS; DIOXANES; EMULSIFYING AGENTS; FORMALDEHYDE; HUMANS; ORGANOMETALLIC COMPOUNDS; PARABENS; PHTHALIC ACIDS; PRESERVATIVES, PHARMACEUTICAL; RISK ASSESSMENT; RISK FACTORS;

EID: 84913621912     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12146     Document Type: Review

References (57)

1. FDA. 1,4-dioxane. 2010. http://www.fda.gov/cosmetics/productsingredients/potentialcontaminants/ucm101566.htm. Accessed June 14, 2014.
2. NTP. Report on carcinogens, 12th edition. 2011. http://ntp.niehs.nih.gov/ntp/roc/twelfth/profiles/Dioxane.pdf. Accessed March 8, 2013.
3. NCI. Bioassay of 1,4-dioxane for possible carcinogenicity. 1978. http://ntp.niehs.nih.gov/ntp/htdocs/LT-rpts/tr080.pdf. Accessed March 8, 2013.
4. Leung HW, Paustenbach DJ,. Cancer risk assessment for dioxane based upon a physiologically-based pharmacokinetic approach. Toxicol Lett 1990: 51 (2): 147-162.
5. Scalia S, Menegatti E,. Assay of 1,4-dioxane in commercial cosmetic products by HPLC. Farmaco 1991: 46 (11): 1365-1370.
6. Black RE, Hurley FJ, Havery DC,. Occurrence of 1,4-dioxane in cosmetic raw materials and finished cosmetic products. J AOAC Int 2001: 84 (3): 666-670.
7. Bronaugh RL,. Percutaneous absorption of cosmetic ingredients. In:, Frost P, Horowitz S, eds. Principles of cosmetics for the dermatologist. St. Louis: The C.V. Mosby Company, 1982: 277.
8. Jackson EM,. Formaldehyde in personal care products. Skin Pharmacol Physiol 2012: 25 (5): 236-240.
9. CARB. Indoor air pollution in California. 2005. http://www.arb.ca.gov/research/indoor/ab1173/rpt0705-c-es.pdf. Accessed June 14, 2013.
10. NTP. Report on carcinogens, 12th edition. 2011. http://ntp.niehs.nih.gov/ntp/roc/twelfth/profiles/formaldehyde.pdf. Accessed March 10, 2013.
11. IARC. IARC monographs on the evaluation of carcinogenic risks to humans, volume 88. 2006. http://monographs.iarc.fr/ENG/Monographs/vol88/mono88-6.pdf. Accessed July 12, 2014.
12. Zhang L, Freeman LE, Nakamura J, et al. Formaldehyde and leukemia: epidemiology, potential mechanisms, and implications for risk assessment. Environ Mol Mutagen 2010: 51 (3): 181-191.
13. FDA. FDA, OSHA Act on Brazilian Blowout. 2012. http://www.fda.gov/cosmetics/productsingredients/products/ucm228898.htm. Accessed June 14, 2014.
14. Pierce JS, Abelmann A, Spicer LJ, et al. Characterization of formaldehyde exposure resulting from the use of four professional hair straightening products. J Occup Environ Hyg 2011: 8 (11): 686-699.
15. de Groot AC, Flyvholm MA, Lensen G, Menne T, Coenraads PJ,. Formaldehyde-releasers: relationship to formaldehyde contact allergy. Contact allergy to formaldehyde and inventory of formaldehyde-releasers. Contact Dermatitis 2009: 61 (2): 63-85.
16. FDA. Nail Care Products. 2012. http://www.fda.gov/cosmetics/productsingredients/products/ucm127068.htm. Accessed June 14, 2014.
17. Lefebvre MA, Meuling WJ, Engel R, et al. Consumer inhalation exposure to formaldehyde from the use of personal care products/cosmetics. Regul Toxicol Pharmacol 2012: 63 (1): 171-176.
18. Audesirk G, Audesirk T,. Effects of inorganic lead on voltage-sensitive calcium channels in N1E-115 neuroblastoma cells. Neurotoxicology 1991: 12 (3): 519-528.
19. FDA. Lead acetate in progressive hair dye products. 2011. http://www.fda.gov/cosmetics/productsingredients/products/ucm143075.htm. Accessed June 14, 2014.
20. Hepp NM,. Determination of total lead in 400 lipsticks on the U.S. market using a validated microwave-assisted digestion, inductively coupled plasma-mass spectrometric method. J Cosmet Sci 2012: 63 (3): 159-176.
21. Pan TL, Wang PW, Al-Suwayeh SA, Chen CC, Fang JY,. Skin toxicology of lead species evaluated by their permeability and proteomic profiles: a comparison of organic and inorganic lead. Toxicol Lett 2010: 197 (1): 19-28.
22. Filon FL, Boeniger M, Maina G, Adami G, Spinelli P, Damian A,. Skin absorption of inorganic lead (PbO) and the effect of skin cleansers. J Occup Environ Med 2006: 48 (7): 692-699.
23. Sun CC, Wong TT, Hwang YH, Chao KY, Jee SH, Wang JD,. Percutaneous absorption of inorganic lead compounds. AIHA J (Fairfax, Va) 2002: 63 (5): 641-646.
24. HPA. Lead toxicological overview. 2012. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1194947332124. Accessed March 7, 2013.
25. Lilley SG, Florence TM, Stauber JL,. The use of sweat to monitor lead absorption through the skin. Sci Total Environ 1988: 76 (2-3): 267-278.
26. Hepp NM, Mindak WR, Cheng J,. Determination of total lead in lipstick: development and validation of a microwave-assisted digestion, inductively coupled plasma-mass spectrometric method. J Cosmet Sci 2009: 60 (4): 405-414.
27. Budtz-Jorgensen E, Bellinger D, Lanphear B, Grandjean P,. An international pooled analysis for obtaining a benchmark dose for environmental lead exposure in children. Risk Anal 2013: 33 (3): 450-461.
28. Cohen AJ, Roe FJ,. Review of lead toxicology relevant to the safety assessment of lead acetate as a hair colouring. Food Chem Toxicol 1991: 29 (7): 485-507.
29. FDA. Hair dye products. 2012. http://www.fda.gov/cosmetics/productsingredients/products/ucm143066.htm. Accessed June 14, 2014.
30. FDA. Parabens. 2011. http://www.fda.gov/cosmetics/productsingredients/products/ucm128042.htm. Accessed June 14, 2014.
31. Soni MG, Carabin IG, Burdock GA,. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol 2005: 43 (7): 985-1015.
32. Elder RL,. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben, and butylparaben. J Am Coll Toxicol 1984: 3: 147-209.
33. Deblois G, Giguere V,. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nat Rev Cancer 2013: 13 (1): 27-36.
34. Byford JR, Shaw LE, Drew MG, Pope GS, Sauer MJ, Darbre PD,. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2002: 80 (1): 49-60.
35. Pugazhendhi D, Pope GS, Darbre PD,. Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines. J Appl Toxicol 2005: 25 (4): 301-309.
36. Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP,. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol 1998: 153 (1): 12-19.
37. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS,. Concentrations of parabens in human breast tumours. J Appl Toxicol 2004: 24 (1): 5-13.
38. Harvey PW, Everett DJ,. Significance of the detection of esters of p- hydroxybenzoic acid (parabens) in human breast tumours. J Appl Toxicol 2004: 24 (1): 1-4.
39. McGrath KG,. An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. Eur J Cancer Prev 2003: 12 (6): 479-485.
40. Barr L, Metaxas G, Harbach CA, Savoy LA, Darbre PD,. Measurement of paraben concentrations in human breast tissue at serial locations across the breast from axilla to sternum. J Appl Toxicol 2012: 32 (3): 219-232.
41. Harvey PW, Darbre P,. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? J Appl Toxicol 2004: 24 (3): 167-176.
42. Okamoto Y, Hayashi T, Matsunami S, Ueda K, Kojima N,. Combined activation of methyl paraben by light irradiation and esterase metabolism toward oxidative DNA damage. Chem Res Toxicol 2008: 21 (8): 1594-1599.
43. Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, and benzylparaben as used in cosmetic products. Int J Toxicol 2008: 27 (Suppl. 4): 1-82.
44. Golden R, Gandy J, Vollmer G,. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit Rev Toxicol 2005: 35 (5): 435-458.
45. FDA. Phthalates and cosmetic products. 2011. http://www.fda.gov/cosmetics/productsingredients/ingredients/ucm128250.htm. Accessed June 14, 2014.
46. Hernandez-Diaz S, Mitchell AA, Kelley KE, Calafat AM, Hauser R,. Medications as a potential source of exposure to phthalates in the U.S. population. Environ Health Perspect 2009: 117 (2): 185-189.
47. CDC. Fourth National Report on Human Exposure to Environmental Chemicals 2009. http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf. Accessed March 9, 2013.
48. Rudel RA, Perovich LJ,. Endocrine disrupting chemicals in indoor and outdoor air. Atmos Environ 2009: 43 (1): 170-181.
49. Heudorf U, Mersch-Sundermann V, Angerer J,. Phthalates: toxicology and exposure. Int J Hyg Environ Health 2007: 210 (5): 623-634.
50. Romero-Franco M, Hernandez-Ramirez RU, Calafat AM, et al. Personal care product use and urinary levels of phthalate metabolites in Mexican women. Environ Int 2011: 37 (5): 867-871.
51. Hubinger JC,. A survey of phthalate esters in consumer cosmetic products. J Cosmet Sci 2010: 61 (6): 457-465.
52. Hubinger JC, Havery DC,. Analysis of consumer cosmetic products for phthalate esters. J Cosmet Sci 2006: 57 (2): 127-137.
53. Bertelsen RJ, Carlsen KC, Calafat AM, et al. Urinary biomarkers for phthalates associated with asthma in Norwegian children. Environ Health Perspect 2013: 121 (2): 251-256.
54. NTP. Report on carcinogens, 12th edition. 2011. http://ntp.niehs.nih.gov/ntp/roc/twelfth/profiles/DiethylhexylPhthalate.pdf. Accessed March 9, 2013.
55. Elsisi AE, Carter DE, Sipes IG,. Dermal absorption of phthalate diesters in rats. Fundam Appl Toxicol 1989: 12 (1): 70-77.
56. SCCNFP. Opinion of the scientific committee on cosmetic products and non-food products intended for consumers concerning diethyl phthalate. 2002. http://ec.europa.eu/health/ph-risk/committees/sccp/documents/out246-en.pdf. Accessed July 12, 2014.
57. SCCP. Opinion on phthalates in cosmetic products. 2007. http://ec.europa.eu/health/ph-risk/committees/sccp/documents/out246-en.pdf. Accessed July 12, 2014.